Helius Medical Technologies Inc expected to post a loss of 13 cents a share - Earnings Preview

Solana Co

07/03/2023 22:49

* Helius Medical Technologies Inc  HSDT.OQ   HSDT.O  is
expected
to report  results on May 9 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Helius Medical
Technologies Inc is for a loss of 13 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 5.7%
in the last three months. ​
    * Wall Street's median 12-month price target for Osisko Gold
Royalties Ltd is C$23​, above​ its last closing price
of C$18.40. ​​​

Previous quarterly performance (using preferred earnings measure
in Canadian dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  0.25        0.25       0.26      Beat    2.5
 Sep. 30 2022  0.21        0.20       0.28      Beat    40
 Jun. 30 2022  0.18        0.18       0.00      Missed  -100.6
                                                        ​
 Mar. 31 2022  0.20        0.19       0.14      Missed  -26.3
 ​​Dec.        0.21        0.21       0.08      Missed  -61
 31 2021                                                
 Sep. 30 2021  0.21        0.21       0.24      Beat    14.8​
 Jun. 30 2021  0.21        0.21       0.18      Missed  -12.4
 Mar. 31 2021  0.20        0.21       0.13      Missed  -38.9
 This summary was machine generated March 7 at 22:49 GMT.  All
figures in US dollars  unless otherwise stated